Condensed Statements of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	$ (954,021)	$ (856,845)	$ (931,279)	$ (835,587)
Net loss	(25,996)	(21,071)	(48,738)	(42,329)
Ending balance	$ (980,017)	$ (877,916)	$ (980,017)	$ (877,916)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Beginning balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Ending balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Ending balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	8,418,684	8,418,684	8,418,684	8,418,684
Ending balance	8,418,684	8,418,684	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	(9,374,605)	(9,277,429)	(9,351,863)	(9,256,171)
Net loss	(25,996)	(21,071)	(48,738)	(42,329)
Ending balance	$ (9,400,601)	$ (9,298,500)	$ (9,400,601)	$ (9,298,500)